VIAL
Compound comparison

Clomiphene vs Enclomiphene

Clomiphene and Enclomiphene are both hormone compounds evaluated on Vial: Clomiphene is FDA approved with clinical-trial evidence, and Enclomiphene is available as a compounded preparation with clinical-trial evidence.

Vial summary · compiled from public records

At a glance

Clomiphene

Category
Hormone
FDA / legal status
FDA Approved
Route
0providers on Vial →

Enclomiphene

Category
Hormone
FDA / legal status
Compoundable
Route
0providers on Vial →

Side by side

FieldClomipheneEnclomiphene
CategoryHormoneHormone
Brand names
FDA / legal statusFDA ApprovedCompoundable
Evidence tierClinical TrialsClinical Trials
Administration route
Compounding accessFDA-approved product, dispensed by prescriptionAvailable through 503A and 503B compounding pharmacies
Providers on Vial0 listed0 listed
Typical price bandVaries by providerVaries by provider

Verified providers offering each

Ranked by Confidence Rating, Vial’s 0 to 100 score built from federal and state public records. The score evaluates the provider, not the compound.

85+ High Confidence70 to 84 Well Documented50 to 69 Limited ConfidenceUnder 50 Flagged

Clomiphene0 top providers

No surfaceable providers currently list Clomiphene on Vial.

See all 0 providers offering clomiphene →

Enclomiphene0 top providers

No surfaceable providers currently list Enclomiphene on Vial.

See all 0 providers offering enclomiphene →

About each compound

About Clomiphene

Clomiphene citrate is an FDA-approved selective estrogen receptor modulator (SERM) historically used for female infertility, now widely prescribed off-label in men to stimulate endogenous testosterone production while preserving fertility. Unlike exogenous testosterone, clomiphene maintains testicular function and spermatogenesis, making it the preferred choice for younger men seeking testosterone optimization who wish to remain fertile.

About Enclomiphene

Enclomiphene is the trans-isomer of clomiphene citrate, isolated for its pure estrogen receptor antagonist activity without the estrogenic agonist effects of the cis-isomer (zuclomiphene). It produces cleaner testosterone stimulation with fewer estrogenic side effects compared to standard clomiphene. Though not yet FDA-approved as a standalone drug, it is available through compounding pharmacies and is preferred by many physicians for its improved tolerability profile.

Descriptions compiled from public FDA records and manufacturer labeling where available. Not medical advice.

This page evaluates compliance signals, not clinical outcomes. Consult a licensed physician before starting any therapy, medication, or treatment. Vial does not provide medical advice.

Related compound comparisons

Other comparisons in the same category.

All compound comparisons →